{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:52:15Z","timestamp":1789077135035,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Artificial sweetener (ArtSw) intakes have been previously associated with higher BMI in observational studies and may promote visceral and skeletal muscle adipose tissue (AT) accumulation. This study aimed to determine whether habitual, long-term ArtSw or diet beverage intakes are related to greater AT depot volumes and anthropometry-related outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A validated diet history questionnaire was administered at baseline, year 7, and year 20 examinations in 3088 men and women enrolled in the Coronary Artery Risk Development in Young Adults cohort (CARDIA), mean age of 25.2 years and mean BMI of 24.5\u2009kg\/m<jats:sup>2<\/jats:sup> at baseline. Volumes of visceral (VAT), intermuscular (IMAT), and subcutaneous adipose tissue (SAT) were assessed by computed tomography at year 25. Linear regression evaluated associations of aspartame, saccharin, sucralose, total ArtSw, and diet beverage intakes with AT volumes, anthropometric measures, and 25-year change in anthropometry. Cox regression estimated associations of ArtSw with obesity incidence. Adjustments were made for demographic and lifestyle factors, total energy intake, and the 2015 healthy eating index.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Total ArtSw, aspartame, saccharin, and diet beverage intakes were positively associated with VAT, SAT, and IMAT volumes (all <jats:italic>p<\/jats:italic><jats:sub>trend<\/jats:sub>\u2009\u2264\u20090.001), but no associations were observed for sucralose intake (all <jats:italic>p<\/jats:italic><jats:sub>trend<\/jats:sub>\u2009&gt;\u20090.05). In addition, total ArtSw, saccharin, aspartame, and diet beverage intakes were associated with greater body mass index, body weight, waist circumference, and their increases over a 25-year period. Except for saccharin (<jats:italic>p<\/jats:italic><jats:sub>trend<\/jats:sub>\u2009=\u20090.13), ArtSw, including diet soda, was associated with greater risks of incident obesity over a median 17.5-year follow-up (all <jats:italic>p<\/jats:italic><jats:sub>trend<\/jats:sub>\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Results suggest that long-term intakes of aspartame, saccharin, or diet soda may increase AT deposition and risk of incident obesity independent of diet quality or caloric intake. Coupled with previous evidence, alternatives to national recommendations to replace added sugar with ArtSw should be considered since both may have health consequences.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41366-023-01336-y","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T13:02:17Z","timestamp":1689253337000},"page":"939-947","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Long-term aspartame and saccharin intakes are related to greater volumes of visceral, intermuscular, and subcutaneous adipose tissue: the CARDIA study"],"prefix":"10.1038","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8010-2530","authenticated-orcid":false,"given":"Brian T.","family":"Steffen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7232-0543","authenticated-orcid":false,"given":"David R.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Yun","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Lees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Shikany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Terry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cora E.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4398-8237","authenticated-orcid":false,"given":"John J.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4053-6729","authenticated-orcid":false,"given":"Lyn M.","family":"Steffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"key":"1336_CR1","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1161\/CIR.0000000000000569","volume":"138","author":"RK Johnson","year":"2018","unstructured":"Johnson RK, Lichtenstein AH, Anderson CAM, Carson JA, Despr\u00e9s JP, Hu FB, et al. Low-calorie sweetened beverages and cardiometabolic health: a science advisory from the American Heart Association. Circulation. 2018;138:e126\u2013e40.","journal-title":"Circulation."},{"key":"1336_CR2","doi-asserted-by":"publisher","first-page":"102462","DOI":"10.1016\/j.dsx.2022.102462","volume":"16","author":"AS Bhagavathula","year":"2022","unstructured":"Bhagavathula AS, Rahmani J, Vidyasagar K, Tesfaye W, Khubchandani J. Sweetened beverage consumption and risk of cardiovascular mortality: a systematic review and meta-analysis. Diabetes Metab Syndr. 2022;16:102462.","journal-title":"Diabetes Metab Syndr"},{"key":"1336_CR3","doi-asserted-by":"publisher","first-page":"E929","DOI":"10.1503\/cmaj.161390","volume":"189","author":"MB Azad","year":"2017","unstructured":"Azad MB, Abou-Setta AM, Chauhan BF, Rabbani R, Lys J, Copstein L, et al. Nonnutritive sweeteners and cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials and prospective cohort studies. Can Med Assoc J. 2017;189:E929\u2013e39.","journal-title":"Can Med Assoc J."},{"key":"1336_CR4","doi-asserted-by":"publisher","first-page":"e0167241","DOI":"10.1371\/journal.pone.0167241","volume":"11","author":"CW Chia","year":"2016","unstructured":"Chia CW, Shardell M, Tanaka T, Liu DD, Gravenstein KS, Simonsick EM, et al. Chronic low-calorie sweetener use and risk of abdominal obesity among older adults: a cohort study. PLoS ONE. 2016;11:e0167241.","journal-title":"PLoS ONE"},{"key":"1336_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1139\/apnm-2016-0346","volume":"42","author":"SS Gul","year":"2017","unstructured":"Gul SS, Hamilton AR, Munoz AR, Phupitakphol T, Liu W, Hyoju SK, et al. Inhibition of the gut enzyme intestinal alkaline phosphatase may explain how aspartame promotes glucose intolerance and obesity in mice. Appl Physiol Nutr Metab. 2017;42:77\u201383.","journal-title":"Appl Physiol Nutr Metab"},{"key":"1336_CR6","doi-asserted-by":"publisher","first-page":"32475","DOI":"10.1074\/jbc.M113.514034","volume":"288","author":"BR Simon","year":"2013","unstructured":"Simon BR, Parlee SD, Learman BS, Mori H, Scheller EL, Cawthorn WP, et al. Artificial sweeteners stimulate adipogenesis and suppress lipolysis independently of sweet taste receptors. J Biol Chem. 2013;288:32475\u201389.","journal-title":"J Biol Chem"},{"key":"1336_CR7","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/jgs.13376","volume":"63","author":"SP Fowler","year":"2015","unstructured":"Fowler SP, Williams K, Hazuda HP. Diet soda intake is associated with long-term increases in waist circumference in a biethnic cohort of older adults: the San Antonio Longitudinal Study of Aging. J Am Geriatr Soc. 2015;63:708\u201315.","journal-title":"J Am Geriatr Soc"},{"key":"1336_CR8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.physbeh.2016.04.047","volume":"164","author":"SPG Fowler","year":"2016","unstructured":"Fowler SPG. Low-calorie sweetener use and energy balance: Results from experimental studies in animals, and large-scale prospective studies in humans. Physiol Behav. 2016;164:517\u201323.","journal-title":"Physiol Behav"},{"key":"1336_CR9","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3945\/ajcn.113.082826","volume":"100","author":"PE Miller","year":"2014","unstructured":"Miller PE, Perez V. Low-calorie sweeteners and body weight and composition: a meta-analysis of randomized controlled trials and prospective cohort studies. Am J Clin Nutr. 2014;100:765\u201377.","journal-title":"Am J Clin Nutr"},{"key":"1336_CR10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41366-020-00704-2","volume":"45","author":"PJ Rogers","year":"2021","unstructured":"Rogers PJ, Appleton KM. The effects of low-calorie sweeteners on energy intake and body weight: a systematic review and meta-analyses of sustained intervention studies. Int J Obes (Lond). 2021;45:464\u201378.","journal-title":"Int J Obes (Lond)"},{"key":"1336_CR11","doi-asserted-by":"publisher","first-page":"e1003700","DOI":"10.1371\/journal.pmed.1003700","volume":"18","author":"F Pishgar","year":"2021","unstructured":"Pishgar F, Shabani M, Quinaglia ACST, Bluemke DA, Budoff M, Barr RG, et al. Adipose tissue biomarkers and type 2 diabetes incidence in normoglycemic participants in the MESArthritis Ancillary Study: a cohort study. PLoS Med. 2021;18:e1003700.","journal-title":"PLoS Med"},{"key":"1336_CR12","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2337\/dc12-0198","volume":"36","author":"PL Wander","year":"2013","unstructured":"Wander PL, Boyko EJ, Leonetti DL, McNeely MJ, Kahn SE, Fujimoto WY. Change in visceral adiposity independently predicts a greater risk of developing type 2 diabetes over 10 years in Japanese Americans. Diabetes Care. 2013;36:289\u201393.","journal-title":"Diabetes Care"},{"key":"1336_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/dom.13513","volume":"21","author":"A Granados","year":"2019","unstructured":"Granados A, Gebremariam A, Gidding SS, Terry JG, Carr JJ, Steffen LM, et al. Association of abdominal muscle composition with prediabetes and diabetes: The CARDIA study. Diabetes Obes Metab. 2019;21:267\u201375.","journal-title":"Diabetes Obes Metab"},{"key":"1336_CR14","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1210\/jc.2017-01113","volume":"102","author":"M Mongraw-Chaffin","year":"2017","unstructured":"Mongraw-Chaffin M, Allison MA, Burke GL, Criqui MH, Matsushita K, Ouyang P, et al. CT-derived body fat distribution and incident cardiovascular disease: the multi-ethnic study of atherosclerosis. J Clin Endocrinol Metab. 2017;102:4173\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"1336_CR15","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.numecd.2017.06.015","volume":"27","author":"GM Kouli","year":"2017","unstructured":"Kouli GM, Panagiotakos DB, Kyrou I, Georgousopoulou EN, Chrysohoou C, Tsigos C, et al. Visceral adiposity index and 10-year cardiovascular disease incidence: the ATTICA study. Nutr Metab Cardiovasc Dis. 2017;27:881\u20139.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1336_CR16","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1161\/ATVBAHA.117.309633","volume":"37","author":"JG Terry","year":"2017","unstructured":"Terry JG, Shay CM, Schreiner PJ, Jacobs DR Jr., Sanchez OA, Reis JP, et al. Intermuscular adipose tissue and subclinical coronary artery calcification in midlife: the CARDIA study (coronary artery risk development in young adults). Arterioscler Thromb Vasc Biol. 2017;37:2370\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1336_CR17","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1002\/oby.20796","volume":"22","author":"SV Eastwood","year":"2014","unstructured":"Eastwood SV, Tillin T, Wright A, Mayet J, Godsland I, Forouhi NG, et al. Thigh fat and muscle each contribute to excess cardiometabolic risk in South Asians, independent of visceral adipose tissue. Obesity (Silver Spring). 2014;22:2071\u20139.","journal-title":"Obesity (Silver Spring)"},{"key":"1336_CR18","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/0895-4356(88)90080-7","volume":"41","author":"GD Friedman","year":"1988","unstructured":"Friedman GD, Cutter GR, Donahue RP, Hughes GH, Hulley SB, Jacobs DR Jr., et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988;41:1105\u201316.","journal-title":"J Clin Epidemiol"},{"key":"1336_CR19","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/00008483-198911000-00003","volume":"9","author":"DR Jacobs Jr.","year":"1989","unstructured":"Jacobs DR Jr., Hahn LP, Haskell WL, Pirie P, Sidney S. Validity and reliability of short physical activity history: Cardia and the Minnesota Heart Health Program. J Cardiopulm Rehabil. 1989;9:448\u201359.","journal-title":"J Cardiopulm Rehabil"},{"key":"1336_CR20","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/S0002-8223(21)01299-2","volume":"91","author":"A McDonald","year":"1991","unstructured":"McDonald A, Van Horn L, Slattery M, Hilner J, Bragg C, Caan B, et al. The CARDIA dietary history: development, implementation, and evaluation. J Am Diet Assoc. 1991;91:1104\u201312.","journal-title":"J Am Diet Assoc"},{"key":"1336_CR21","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.jand.2018.05.021","volume":"118","author":"SM Krebs-Smith","year":"2018","unstructured":"Krebs-Smith SM, Pannucci TE, Subar AF, Kirkpatrick SI, Lerman JL, Tooze JA, et al. Update of the Healthy Eating Index: HEI-2015. J Acad Nutr Diet. 2018;118:1591\u2013602.","journal-title":"J Acad Nutr Diet"},{"key":"1336_CR22","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1038\/oby.2008.284","volume":"16","author":"SP Fowler","year":"2008","unstructured":"Fowler SP, Williams K, Resendez RG, Hunt KJ, Hazuda HP, Stern MP. Fueling the obesity epidemic? Artificially sweetened beverage use and long-term weight gain. Obesity (Silver Spring). 2008;16:1894\u2013900.","journal-title":"Obesity (Silver Spring)"},{"key":"1336_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jss.2015.12.008","volume":"202","author":"J Fawley","year":"2016","unstructured":"Fawley J, Gourlay DM. Intestinal alkaline phosphatase: a summary of its role in clinical disease. J Surg Res. 2016;202:225\u201334.","journal-title":"J Surg Res"},{"key":"1336_CR24","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3390\/microorganisms10040746","volume":"10","author":"GM Santos","year":"2022","unstructured":"Santos GM, Ismael S, Morais J, Ara\u00fajo JR, Faria A, Calhau C, et al. Intestinal alkaline phosphatase: a review of this enzyme role in the intestinal barrier function. Microorganisms. 2022;10:746.","journal-title":"Microorganisms."},{"key":"1336_CR25","doi-asserted-by":"publisher","first-page":"7003","DOI":"10.1073\/pnas.1220180110","volume":"110","author":"K Kaliannan","year":"2013","unstructured":"Kaliannan K, Hamarneh SR, Economopoulos KP, Nasrin Alam S, Moaven O, Patel P, et al. Intestinal alkaline phosphatase prevents metabolic syndrome in mice. Proc Natl Acad Sci USA. 2013;110:7003\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1336_CR26","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.3390\/cells11091424","volume":"11","author":"Z Cai","year":"2022","unstructured":"Cai Z, Huang Y, He B. New insights into adipose tissue macrophages in obesity and insulin resistance. Cells. 2022;11:1424.","journal-title":"Cells."},{"key":"1336_CR27","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","volume":"56","author":"PD Cani","year":"2007","unstructured":"Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56:1761\u201372.","journal-title":"Diabetes."},{"key":"1336_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.molmet.2013.06.005","volume":"2","author":"E Luche","year":"2013","unstructured":"Luche E, Cousin B, Garidou L, Serino M, Waget A, Barreau C, et al. Metabolic endotoxemia directly increases the proliferation of adipocyte precursors at the onset of metabolic diseases through a CD14-dependent mechanism. Mol Metab. 2013;2:281\u201391.","journal-title":"Mol Metab"},{"key":"1336_CR29","doi-asserted-by":"publisher","first-page":"E319","DOI":"10.1152\/ajpendo.00277.2018","volume":"316","author":"M Clemente-Postigo","year":"2019","unstructured":"Clemente-Postigo M, Oliva-Olivera W, Coin-Arag\u00fcez L, Ramos-Molina B, Giraldez-Perez RM, Lhamyani S, et al. Metabolic endotoxemia promotes adipose dysfunction and inflammation in human obesity. Am J Physiol Endocrinol Metab. 2019;316:E319\u2013e32.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1336_CR30","doi-asserted-by":"publisher","first-page":"1801301","DOI":"10.1080\/19490976.2020.1801301","volume":"12","author":"M S\u00e1nchez-Tapia","year":"2020","unstructured":"S\u00e1nchez-Tapia M, Miller AW, Granados-Portillo O, Tovar AR, Torres N. The development of metabolic endotoxemia is dependent on the type of sweetener and the presence of saturated fat in the diet. Gut Microbes. 2020;12:1801301.","journal-title":"Gut Microbes"},{"key":"1336_CR31","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3390\/metabo11080546","volume":"11","author":"S Muli","year":"2021","unstructured":"Muli S, Goerdten J, Oluwagbemigun K, Floegel A, Schmid M, N\u00f6thlings U. A systematic review of metabolomic biomarkers for the intake of sugar-sweetened and low-calorie sweetened beverages. Metabolites. 2021;11:546.","journal-title":"Metabolites."},{"key":"1336_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12263-018-0607-5","volume":"13","author":"JA Rothwell","year":"2018","unstructured":"Rothwell JA, Madrid-Gambin F, Garcia-Aloy M, Andres-Lacueva C, Logue C, Gallagher AM, et al. Biomarkers of intake for coffee, tea, and sweetened beverages. Genes Nutr. 2018;13:15.","journal-title":"Genes Nutr"},{"key":"1336_CR33","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1016\/j.cell.2022.07.016","volume":"185","author":"J Suez","year":"2022","unstructured":"Suez J, Cohen Y, Vald\u00e9s-Mas R, Mor U, Dori-Bachash M, Federici S, et al. Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance. Cell. 2022;185:3307\u201328.e19.","journal-title":"Cell."},{"key":"1336_CR34","doi-asserted-by":"publisher","first-page":"908868","DOI":"10.3389\/fendo.2022.908868","volume":"13","author":"D Wu","year":"2022","unstructured":"Wu D, Wang H, Xie L, Hu F. Cross-talk between gut microbiota and adipose tissues in obesity and related metabolic diseases. Front Endocrinol (Lausanne). 2022;13:908868.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1336_CR35","doi-asserted-by":"publisher","first-page":"15718","DOI":"10.1073\/pnas.0407076101","volume":"101","author":"F B\u00e4ckhed","year":"2004","unstructured":"B\u00e4ckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 2004;101:15718\u201323.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1336_CR36","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/msb.2010.46","volume":"6","author":"GG Muccioli","year":"2010","unstructured":"Muccioli GG, Naslain D, B\u00e4ckhed F, Reigstad CS, Lambert DM, Delzenne NM, et al. The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol. 2010;6:392.","journal-title":"Mol Syst Biol"},{"key":"1336_CR37","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3390\/nu11081835","volume":"11","author":"E \u015awiderska","year":"2019","unstructured":"\u015awiderska E, Podolska M, Strycharz J, Szwed M, Abramczyk H, Bro\u017cek-P\u0142uska B, et al. Hyperglycemia changes expression of key adipogenesis markers (C\/EBP\u03b1 and PPAR\u03b3)and morphology of differentiating human visceral adipocytes. Nutrients. 2019;11:1835.","journal-title":"Nutrients."},{"key":"1336_CR38","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/advances\/nmz137","volume":"11","author":"DJ Mela","year":"2020","unstructured":"Mela DJ, McLaughlin J, Rogers PJ. Perspective: standards for research and reporting on low-energy (\"artificial\") sweeteners. Adv Nutr. 2020;11:484\u201391.","journal-title":"Adv Nutr"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-023-01336-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-023-01336-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-023-01336-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T16:04:00Z","timestamp":1695225840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-023-01336-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1336"],"URL":"https:\/\/doi.org\/10.1038\/s41366-023-01336-y","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,13]]},"assertion":[{"value":"5 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}